Advertisement

Topics

Report: Corporate venture capital is catalyzing groundbreaking biomedical innovation in the United States

08:00 EDT 10 Oct 2018 | PhRMA

Venture capital is increasingly becoming the growing force for financing biotech and other startups, fueling medical advances in the U.S.  A new report released today from TEConomy, examines the role and impact of one specific player in that ecosystem: biopharmaceutical corporate venture capital (CVC) funds, which often support early stage medical innovation.

Original Article: Report: Corporate venture capital is catalyzing groundbreaking biomedical innovation in the United States

NEXT ARTICLE

More From BioPortfolio on "Report: Corporate venture capital is catalyzing groundbreaking biomedical innovation in the United States"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...